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and Gregg E. Homanics*
Departments of Anesthesiology, Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA
Background: Emerging research implicates ethanol (EtOH)-induced epigenetic
modifications in regulating gene expression and EtOH consumption. However,
consensus on specific epigenetic modifications induced by EtOH has not yet emerged,
making it challenging to identify mechanisms and develop targeted treatments. We
hypothesized that chronic intermittent EtOH (CIE) induces persistent changes in histone
modifications across the cerebral cortex (CCx), nucleus accumbens (NAc), and prefrontal
cortex (PFC), and that these histone modifications are altered in a knock-in mouse strain
with altered sensitivity to EtOH.
Methods: C57BL/6J (B6) mice and α1SHLA knockin mice on a B6 background were
exposed to 16 h of vapor EtOH or room air followed by 8 h of room air for 4 consecutive
days and sacrificed at multiple time points up to 72 h following exposure. Histone
modifications were assessed using Western blot and dot blot. RT-qPCR was used to
study expression of chromatin modifying enzymes in NAc and PFC.
Results: In NAc, CIE significantly increased acetylation of histone subunit H3 at lysine
9 (H3K9ac) but not lysine 14 (H3K14ac) or lysine 27 (H3K27ac). In PFC, CIE significantly
increased H3K9ac but not H3K14 or H3K27ac. There were no significant changes at 8 or
72 h after EtOH exposure in either NAc or PFC. CIE was also associated with increased
expression of Kat2b, Kat5, and Tet1 in NAc but not PFC. In CCx, CIE had a significant
effect on levels of H3K18ac; there was also a significant effect of the α1SHLA mutation
on levels of H3K27me3, H3K14ac, and H3K18ac as well as a trend for H3S10pK14ac.
Conclusions: The EtOH-induced histone modifications observed were transient and
varied significantly between brain regions. A genetic mutation that altered sensitivity to
EtOH was associated with altered induction of histone modifications during CIE. These
results have implications for studying EtOH-induced histone modifications and EtOH
sensitivity.
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Introduction
Repeated ethanol (EtOH) exposure is associated with molecular
adaptations in the brain that underlie its potential for dependence
(Robinson and Berridge, 1993; Koob, 2003). Notably, EtOH
exposure leads to widespread changes in gene expression across
several brain structures in both rodents (Kerns et al., 2005;Wolen
et al., 2012) and humans (Mayfield et al., 2002; Ponomarev et al.,
2012), with the number of altered genes dependent on the brain
region studied (Melendez et al., 2012). Despite a considerable
number of studies demonstrating EtOH-induced changes in gene
expression in the brain, mechanisms by which EtOH selectively
regulates these genes are only recently emerging.
Gene expression is regulated by epigeneticmechanisms, which
refer to a broad group of modifications to chromatin that do
not alter nucleotide sequence and include DNA methylation,
modifications to histone N-terminal tails, and noncoding RNAs
(Kouzarides, 2007). In particular, modifications to histone N-
terminal tails regulate the accessibility of DNA to transcription
factors by altering the affinity between DNA and histones.
Among the best characterized modifications, acetylation of lysine
residues on histone N-terminal tails is associated with gene
activation while methylation of these same residues is associated
with gene repression. Additionally, these histone modifications
are catalyzed by a large group of histone modifying enzymes and
are rapidly inducible and reversible, forming a critical component
of cellular adaptation to its environment (Smith and Shilatifard,
2010). Because of their plasticity and role in regulating gene
expression in response to an environmental stressor, histone
modifications have been increasingly studied for their role in
drug-induced behavior and addiction (Robison and Nestler,
2011).
Emerging evidence indicates EtOH exposure and withdrawal
lead to global changes in histone modifications across several
brain structures that are critical for EtOH-related behaviors and
drinking. In the amygdala, EtOH exposure is associated with
increased histone acetylation and withdrawal is associated with
decreased histone acetylation (Pandey et al., 2008; Sakharkar
et al., 2012; Moonat et al., 2013); moreover, modulating histone
deacetylase (HDAC) activity in the amygdala reduces anxiety-
like behaviors during withdrawal and alters EtOH consumption
(Moonat et al., 2013; You et al., 2014). Potentiation of the
mesolimbic pathway by EtOH is also associated with altered
histonemodifications in the ventral tegmental area (VTA) (Arora
et al., 2013) and nucleus accumbens (NAc) (Simon-O’Brien
et al., 2014; Sprow et al., 2014). In the hippocampus, EtOH-
induced histone modifications regulate expression of brain
derived neurotrophic factor (BDNF) exons (Stragier et al., 2014).
Globally modulating histone modifying also alters behavior.
Pretreatment with an HDAC inhibitor decreased aversion and
increased extinction time on a conditioned place aversion
assay involving EtOH as well as potentiating the effect of
EtOH on histone acetylation in the prefrontal cortex (PFC)
(Pascual et al., 2012). While studies have focused on increased
histone acetylation following EtOH exposure, acute EtOH is
associated with both histone acetylation and deacetylation at gene
promoters in the cerebral cortex (CCx), suggesting induction
of multiple chromatin remodeling pathways (Finegersh and
Homanics, 2014).
While a diverse group of studies on epigenetic mechanisms
of EtOH has emerged, several critical questions remain to be
addressed. Notably, published studies of EtOH-induced histone
modifications have focused on acute and chronic EtOH exposure
as well as withdrawal. However, alcohol use disorder (AUD)
in humans is associated with chronically relapsing patterns of
EtOH drinking (for review, see Koob, 2013), so that persistence
of epigenetic modifications following a binge episode may be
important for reinforcing further consumption. In mice, chronic
intermittent EtOH (CIE) is also associated with escalation of
EtOH drinking up to 1 week following the last dose of EtOH
(Lopez and Becker, 2005; Griffin et al., 2009). Published studies
have also generally focused on a single critical brain region or
network for studying EtOH-induced epigenetic effects; however,
brain regions have distinct transcriptional profiles in response to
EtOH exposure (Kerns et al., 2005; Melendez et al., 2012) and
even two sub-structures of the amygdala have distinct induction
of histone acetylation following EtOH exposure (Pandey et al.,
2008). Genetic diversity also contributes to altered susceptibility
to AUD in humans. Similarly, mouse strains show a wide range
of voluntary EtOH consumption (Belknap et al., 1993) and
EtOH-induced behaviors (Rustay et al., 2003). These behavioral
differences are related to distinct patterns of EtOH-induced gene
expression in strains with high vs. low EtOH preference (Kerns
et al., 2005), suggesting differences in EtOH-induced epigenetic
modifications.
This paper addresses whether EtOH-induced changes to
histone modifications persist beyond acute EtOH withdrawal,
whether altered histone modifications generalize across brain
structures, and if genotype affects EtOH-induced histone
modifications. To study these factors, we examined induction
of histone acetylation in NAc, and PFC following CIE through
72 h of withdrawal in wild type mice. In a separate experiment,
we studied EtOH-induced histone modifications in knock-in
mice containing two point mutations in the α1 subunit of the
GABAA receptor (S270H, L277A) (α1SHLA). This mutation
reduces sensitivity of post-synaptic GABAA receptors to EtOH
(Borghese et al., 2006;Werner et al., 2006), decreases sensitivity to
motor-impairing effects of EtOH (Werner et al., 2006), increases
sensitivity to the anxiolytic effects of EtOH (Werner et al., 2006),
and significantly alters gene expression in CCx compared to
WT littermates (Harris et al., 2011). This experiment will also
investigate basal and EtOH-induced histone modifications in this
genetically engineered rodent strain. Overall, results from these
experiments are expected to elucidate new epigenetic effects and
improve design of mechanistic studies of EtOH exposure.
Methods
All experiments were approved by the Institutional Animal
Care and Use Committee of the University of Pittsburgh and
conducted in accordance with the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals. Mice
were habituated to the University of Pittsburgh animal facility
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for at least 1 week prior to initiation of experiments. Mice were
housed under 12 h light/dark cycles and had ad libitum access to
food and water.
Experiment 1
This experiment was performed using 8- to 12-week-old, EtOH-
naïve, specific pathogen free male C57BL/6J mice from the
Jackson Laboratory (20–30 g). Male mice were used because the
estrous cycle influences EtOH drinking behaviors in females
(Roberts et al., 1998; Ford et al., 2002). Mice were randomly
divided into groups receiving either chronic intermittent vapor
EtOH (E) or room air (C). For exposures, mice were injected
with either 1 g/kg EtOH (0.01ml/g of 10% EtOH in 0.9% saline
i.p.) or an equivalent volume of 0.9% saline i.p. Immediately
following injection, mice were placed in one of two identical
custom-built vapor chambers (16"× 16"× 24" constructed from
0.5" plexiglass). One chamber was used to deliver room air and
the other vaporized EtOH. Flow rate, vaporization temperature,
and exposure time were optimized to achieve consistent blood
EtOH concentrations (BEC) without the use of pyrazole. Room
air was flowed into two heated Erlenmeyer flasks at a rate of
8 L/min; one flask received EtOH at a rate of 160µl/min by a
syringe pump (Harvard apparatus, Holliston, MA, USA) while
the other flask received no EtOH. Mice were placed in vapor
chambers immediately after injections overnight from 17:00 to
09:00 followed by room air from 09:00 to 17:00 for 4 consecutive
days. Temperature of the chambers was monitored daily and
averaged 78◦F at the end of 16 h of exposure. Blood was collected
from the tail vein immediately following the first EtOH exposure.
BEC in plasma were measured using an Analox EtOH analyzer
(AM1, Analox Instruments, London, UK).
Mice were sacrificed immediately following the fourth night
of vapor EtOH (chronic EtOH), 8 h later (8 h withdrawal),
or 72 h later (72 h withdrawal). NAc and PFC were extracted
immediately using an ice cold adult mouse brain slicer matrix
with 1mm coronal section slice intervals (Zivic Instruments,
Pittsburgh, PA, USA). PFC was extracted on the first slice where
the cortex was visible. NAc was defined as tissue wrapped around
the anterior commissure inferior to the caudate and superior
to the olfactory tubercle. Tissue was flash frozen and stored
at−80◦C until processing.
For Western blots, histone proteins were extracted using
the Epigentek Total Histone Extraction Kit according to the
manufacturer’s protocol (Epigentek, Farmingdale, NY, USA).
Protein concentration was quantified using a Bradford assay
and 3µg of protein were loaded into a 12% Novex Tris-glycine
gel (Life Technologies, Carlsbad, CA, USA). Proteins were
transferred to a nitrocellulose membrane using the iBlot system
(Life Technologies). For antibody blots, membranes were blocked
by Odyssey buffer (Licor Biosciences, Lincoln, NE, USA) for
1 h at room temperature. Then membranes were incubated with
primary antibody overnight at 4◦C. Antibodies were obtained
from the Acetyl-Histone H3 Antibody Sampler Kit (Cell Signal
Technologies, #9927) and included H3K9ac (#9649), H3K14ac
(#7627), H3K27ac (#8173), and Total H3 (#4499). Blots were
washed 3× in TBST for 5min each then an anti-rabbit fluorescent
secondary antibody (Licor Biosciences) was added and incubated
for 1 h at room temperature. The secondary antibody was washed
3× in TBST for 5min each and fluorescence was visualized
using the Odyssey Infrared Imaging System (Licor Biosciences).
Membranes were stripped three times using stripping buffer
(LiCor Biosciences) between incubations with primary antibody
and visualized afterward to ensure there was no detectable
antibody signal between blots.
Acetyl-histone bands were normalized to the total intensity
of histone subunit H3. All samples were run in duplicate and
the average normalized intensity between duplicates used for
analysis. A One-Way ANOVA with Bonferroni post-hoc tests was
used to compare histone modifications between groups.
For RT-qPCR experiments, total RNA was isolated using
TRIzol (Life Technologies) according to the manufacturer’s
protocol, purified with on-column DNase digestion using the
RNeasy Mini kit (Qiagen, Venlo, Netherlands), and 1µg of
RNA was synthesized into cDNA using reverse transcriptase
(RT) (Bio-Rad, Hercules, CA, USA). For quantification, samples
were run with each primer pair and SYBR green fluorescent
master mix (Bio-Rad) and visualized using a Bio-Rad iCycler. All
primers were optimized for 90–110% efficiency at the following
conditions: 10min at 95◦C (initial denaturation) followed by 40
cycles of 30 s at 95◦C (denaturation), 1min at 60◦C (annealing),
and 30 s at 72◦C (extension). Primer sequences for β-actin,
Hdac2, Hdac11, Kat2b, Kat5, Ehmt2, and Tet1 are shown in
Table 1. Threshold cycle (Ct) values were calculated for each well
and duplicate values averaged. The difference between specific
genes and β-actin (1Ct) was calculated for each animal and
normalized to the average of saline-treated animals (11Ct). Fold
change over room air controls was calculated for each animal
using the following formula: 2−11Ct. A Two-Way repeated
measures ANOVA with Bonferroni post-hoc tests was used to
compare gene expression between groups.
Experiment 2
α1SHLA knockin mice and littermate controls were on a mixed
C57Bl/6J× Strain 129SvJ background that had been backcrossed
to C57BL/6J for three generations. Mice were randomly divided
into groups receiving either vapor EtOH (E) or room air (C).
For exposures, mice were given the alcohol dehydrogenase
inhibitor pyrazole (68mg/kg i.p.) followed by a priming dose
of 1.5 g/kg EtOH (0.02ml/g of 7.5% EtOH in 0.9% saline i.p.)
or an equivalent volume of saline i.p. and then placed into the
vapor chambers for 16 h of EtOH vapor exposure (16:00–08:00)
followed by 8 h in room air (08:00–16:00). Pyrazole is an alcohol
dehydrogenase inhibitor that was used to maintain high BECs
during ethanol vapor exposure. Compressed air at rate of 8 L/min
was flowed over two heated flasks; one flask received EtOH at a
rate of 110µl/min by a syringe pump (Harvard apparatus) while
the other flask received no EtOH; the vapor was then passed
into two identical custom-built vapor chambers (16" × 16" ×
24" constructed from 0.5" plexiglass). The exposure process was
repeated for a total of four cycles.
For each treatment group, mice were sacrificed and brain
tissue collected at three endpoints: 1 h into the first exposure
(acute exposure), immediately following the fourth exposure
(chronic exposure), and 9 h into the withdrawal period after
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TABLE 1 | Primer sequences for RT-qPCR experiments.
Gene Forward primer (5′ → 3′) Reverse primer (5′ → 3′)
β-actin TCATGAAGTGTGACGTTGACATCCGT CCTAGAAGCATTTGCGGTGCACGATG
Hdac2 GACATATGAGACTGCAGTTGC ACCTCCTTCACCTTCATCCTC
Hdac11 AATGGGGCAAGGTGATCAAC AGCCACCACCAACATTGATG
Kat2b TACCTCTTCACCTGCGTCCACAAA TCACACCCTGTTCAATACTGGGCT
Kat5 AGGACATCAGTGGCCGAAAG GTGATCTGGACCGGGATTGG
Ehmt2 TGCCTATGTGGTCAGCTCAG GGTTCTTGCAGCTTCTCCAG
Tet1 CGAAAGAACAGCCACCAGAT TTGCTCTTCTTCCCCATGAC
the fourth exposure (withdrawal). At sacrifice, CCx was quickly
dissected, flash-frozen in liquid nitrogen, and stored at −80◦C.
For the EtOH treatment group, six animals per endpoint were
designated for each genotype (WT, KI), for a total of 36
samples. For the room air group, two animals per endpoint were
designated within genotype; the three endpoints (six animals)
were pooled into one room air group as the control for each
genotype, for a total of 12 samples.
Histone proteins were extracted using the Epigentek Total
Histone Extraction Kit according to the manufacturer’s protocol
(Epigentek) and concentration of the lysate was determined by
a Bradford assay. Relative changes in modified H3 levels were
measured using the dot blot assay. In this assay, 4–8µg of
histone protein lysate per sample was spotted in random order
on nitrocellulose in a 6 × 8 grid either by hand or using a
vacuum manifold. Membranes were blocked in Odyssey buffer
(Licor Biosciences) and incubated overnight simultaneously
with primary total- and modified-H3 antibodies. Membranes
were then incubated with fluorescent secondary antibodies and
visualized in two channels (680 and 800 nm) using the Odyssey
Infrared Imaging System (Licor Biosciences). Modified histone
levels were determined using the integrated signal intensities
in the following manner. First, a ratio of the modified H3 to
total H3 intensity was calculated for each sample. This ratio was
normalized to the average of the room air group, within genotype.
The average of the six normalized ratios was then calculated for
each endpoint. Three replicate blots were done for each modified
histone and a Two-Way ANOVA with Bonferroni post-hoc tests
was performed on the averaged replicates to assess the effect of
endpoint and genotype.
Results
Experiment 1
The goal of this experiment was to compare levels of histone
acetylation following CIE and withdrawal in NAc and PFC. Mice
were injected with either 1 g/kg EtOH or saline then immediately
placed into a vapor EtOH chamber or room air for 16 h overnight
for 4 consecutive days; they were sacrificed immediately
following the final vapor EtOH exposure (chronic EtOH), 8 h
afterward (8 h withdrawal), or 72 h afterward (Figure 1A). BECs
were measured after the first exposure cycle and averaged 238 ±
19.2 mg/dl (mean± SEM). NAc and PFCwere removed and used
to compare levels of histonemodifications and gene expression of
chromatinmodifying enzymes to room air controls.Western blot
statistical comparisons are summarized in Tables 2, 3.
Levels of H3K9ac, H3K14ac, and H3K27ac were assessed in
NAc using Western blot (Figure 2A). There was a significant
effect of EtOH exposure on levels of H3K9ac (F = 4.55,
p < 0.05); post-hoc analysis revealed increased levels of H3K9ac
following chronic EtOH (p < 0.05) (Figure 2B). There was also
a significant effect of EtOH exposure on level levels of H3K14ac
(F = 6.61, p < 0.01); post-hoc analysis revealed a trend for
an increase in H3K14ac following chronic EtOH (p = 0.056)
(Figure 2C). There was also a significant effect of EtOH exposure
on levels of H3K27ac (F = 3.56, p < 0.05) but no significant
findings on post-hoc analysis (Figure 2D).
Histone acetylation was also assessed by Western blot in PFC
(Figure 3A). There was a significant effect of EtOH exposure
on levels of H3K9ac (F = 4.028, p < 0.05); post-hoc analysis
revealed increased levels of H3K9ac following chronic EtOH
(p < 0.05) (Figure 3B). There were no significant effects of
EtOH exposure on levels of H3K14ac (Figure 3C) or H3K27ac
(Figure 3D) in the mPFC.
Chromatin modifications are carried out by a diverse group
of enzymes that are rapidly induced by environmental stimuli
(Smith and Shilatifard, 2010). We performed RT-qPCR in the
chronic EtOH group to assess expression of chromatinmodifying
enzymes that may be involved in mediating the epigenetic
effects of EtOH. These included the histone deacetylases (HDAC)
Hdac2 and Hdac11 previously shown to be down-regulated
by acute EtOH (Finegersh and Homanics, 2014), the histone
acetyltransferases Kat2b and Kat5 that are associated with the
cAMP-response element binding protein (CREB), the histone
lysine methyltransferase Ehmt2, and a component of an active
DNA demethylation pathway Tet1. In PFC, there was no
significant effect of chronic EtOH exposure on expression of
these enzymes (Figure 4A). In NAc, there was a significant effect
of chronic EtOH exposure on gene expression [F(1, 7) = 11.66,
p < 0.05]; post-hoc analysis revealed significantly increased
expression of Kat5 (p < 0.05) and Tet1 (p < 0.01) and a trend
for increased expression of Kat2b (p = 0.08) (Figure 4B).
Experiment 2
Based on results from Experiment 1, we tested whether observed
changes in histone modifications in NAc and PFC generalized
to CCx and were affected by gene mutations conferring changes
in EtOH-induced gene expression and behavior. To study these
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FIGURE 1 | Experimental Design. (A) In Experiment 1, mice were
injected with either 1 g/kg EtOH or saline then immediately placed into
a vapor EtOH chamber or room air for 16 h overnight (1700 to 0900)
for 4 consecutive days; they were sacrificed immediately following the
final vapor EtOH exposure (chronic EtOH), 8 h following the final vapor
EtOH exposure (8 h withdrawal), or 72 h following the final vapor EtOH
exposure and their NAc and PFC were flash frozen and stored for
analysis. (B) In Experiment 2, mice were injected with pyrazole and
either 1.5 g/kg EtOH or saline then immediately placed into a vapor
EtOH chamber or room air for 16 h overnight (1700 to 0900) for 4
consecutive days; they were sacrificed 1 h into the first day (acute
EtOH), immediately following the final vapor EtOH exposure (chronic
EtOH), or 9 h following the final vapor EtOH exposure (9 h withdrawal)
and their CCx was flash frozen and stored for analysis. In both
experiments, blood EtOH concentrations were collected by tail nick
immediately following the first vapor EtOH session.
TABLE 2 | Summary of ANOVAs of histone modifications by brain region.
Brain Region H3K9ac H3K14ac H3K18ac H3K27ac H3S10phK14ac H3K27me3
Nucleus Accumbens EtOH** EtOH** – EtOH** – –
Prefrontal Cortex EtOH** N.S. – N.S. – –
Cerebral Cortex N.S. G** G + EtOH** – G* G***
EtOH, effect of EtOH treatment; G, effect of genotype; N.S., not significant—not done, *p < 0.1, **p < 0.05, ***p < 0.01.
TABLE 3 | Summary of Bonferroni post-hoc tests for Experiment 1.
Nucleus accumbens Prefrontal cortex
Treatment H3K9ac H3K14ac H3K27ac H3K9ac H3K14ac H3K27ac
Chronic EtOH 0.03 0.06 0.14 0.02 0.12 0.39
8 h withdrawal 0.99 0.13 0.11 0.92 0.58 0.51
72 h withdrawal 0.99 0.86 0.99 0.99 0.99 0.99
effects, we comparedWT and α1SHLA knockin littermates. Mice
were injected with pyrazole and either 1.5 g/kg EtOH or saline
then placed into a vapor EtOH chamber or room air chamber
for 16 h overnight for 4 consecutive days; they were sacrificed
1 h into the first day (acute EtOH), immediately following the
final vapor EtOH exposure (chronic EtOH), or 9 h afterward
(9 h withdrawal) (Figure 1B). BECs were measured after the first
exposure cycle and were in the range of 150–300mg/dl. We
chose histone modifications to study based on those previously
reported to be involved in addiction. Notably, our previous study
showed that acute EtOH alters H3K27me3 and H3K9,14ac at
specific gene promoters in CCx (Finegersh and Homanics, 2014).
H3S10pK14ac was studied because it is induced in the striatum
following cocaine administration (Stipanovich et al., 2008) and
in hepatocytes following EtOH exposure (Lee and Shukla, 2007)
but there are no published studies that describe its levels in CCx
following EtOH exposure. H3K18ac was studied because it is
enriched at the transcriptional start site of actively transcribed
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FIGURE 2 | Chronic intermittent EtOH transiently potentiates
histone acetylation in NAc. (A) Western blot showing one sample
from 6/group analyzed in duplicate. Western blot revealed (B) a
significant effect of EtOH exposure on H3K9ac (p < 0.05) and
increased levels immediately following EtOH exposure, (C) a
significant effect of EtOH on levels of H3K14ac (p < 0.01) and a
trend for increased levels immediately following EtOH exposure, and
(D) a significant effect of EtOH on levels of H3K27ac (p < 0.05).
*p < 0.01, #p = 0.056, n = 6/group, data presented as mean ±
SEM.
gene promoters (Wang et al., 2008; Ernst et al., 2011). Dot blot
statistical results are summarized in Tables 2, 4.
Using dot blot, we identified a significant effect of genotype
on levels of H3K27me3 [F(1, 40) = 8.12, p < 0.01] but no
effect of EtOH exposure or interaction; post-hoc analysis revealed
a nonsignificant trend for decreased levels of H3K27me3 after
acute EtOH exposure in α1 SHLA compared to WT littermates
(p = 0.07) (Figure 5A). There was also a nonsignificant trend
for an effect of genotype on levels of H3S10pK14ac [F(1, 40) =
3.02, p = 0.09] but no effect of EtOH exposure, interaction, or
significant post-hoc effects (Figure 5B).
We also assessed levels of histone acetylation in CCx by
studying H3K9ac, H3K14ac, and H3K18ac using dot blot. There
was no significant effect of EtOH treatment or genotype on
levels of H3K9ac (Figure 5C). There was a significant effect of
genotype on levels of H3K14ac [F(1, 40) = 6.57, p < 0.05]
but no effect of EtOH exposure, interaction, or significant post-
hoc effects (Figure 5D). We also identified a significant effect for
both genotype [F(1, 40) = 4.28, p < 0.05] and EtOH exposure
[F(3, 40) = 4.13, p < 0.05] on levels of H3K18ac but no
significant interaction; post-hoc analysis revealed increased levels
of H3K18ac in the chronic EtOH group compared to room air
exposure in WT mice (p < 0.05) (Figure 5E).
Discussion
Our results demonstrate that for the histone modifications
studied, changes induced by EtOH are transient, differ
significantly between brain regions, and are altered in knockin
mice that have altered responses to EtOH. Importantly,
Experiment 2 of this study identified a significant effect of
the GABAA receptor α1SHLA mutation on CCx levels of
H3K27me3, H3K14ac, and H3K18ac as well as a trend for
H3S10pK14ac, suggesting epigenetic modifications underlie
observed differences in gene expression (Harris et al., 2011) and
basal behavior (Werner et al., 2006) in this strain. Additionally,
Experiment 1 of this study identified a large effect of chronic
EtOH on histone acetylation in NAc but not in PFC, reflecting
sensitivity of different brain regions to EtOH-induced histone
modifications.
It is notable that at least one histone acetylation modification
was potentiated by CIE in the NAc, CCx, and PFC; additionally,
there were no significant differences in histone acetylation
in these structures 8–9 h after mice were removed from
EtOH vapor. Potentiation of histone acetylation during EtOH
exposure and deacetylation during early withdrawal indicates
a complex balance between chromatin modifying enzymes that
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FIGURE 3 | Chronic intermittent EtOH transiently potentiates
histone acetylation in the PFC. (A) Western blot showing one
sample from 5/group analyzed in duplicate. Western blot revealed
(B) a significant effect of EtOH exposure on H3K9ac (p < 0.05) and
increased levels immediately following EtOH exposure but no
significant effect of EtOH exposure on (C) H3K14ac or (D)
H3K27ac levels in mPFC. *p < 0.01, n = 5/group, data presented as
mean ± SEM.
likely depends on blood EtOH levels. Moreover, this pattern
implicates early EtOH withdrawal as a critical period for
epigenetic remodeling, since the histone modifications studied
were altered within 8 h of being removed from EtOH vapor
in the NAc and PFC. Interestingly, blood EtOH levels likely
remain elevated during this early withdrawal period (Goldstein
and Zaechelein, 1983). If EtOH-induced histone modifications
diminish while blood EtOH levels are elevated, there may be a
role for tolerance in EtOH’s epigenetic effects. This role could be
studied by correlating blood EtOH levels to induction of histone
modifications at multiple time points. A previous study showed
increased histone deacetylation 24 h following chronic EtOH
exposure in the amygdala (Pandey et al., 2008) and our results
indicate these changes occur much earlier in other brain regions.
Studying specific windows where large-scale epigenetic changes
occur, like the early EtOH withdrawal period identified in this
study, will be crucial in finding new epigenetic mechanisms
important for EtOH action. Moreover, most studies of EtOH-
induced histone deacetylation have used nonspecific HDAC
inhibitors like Trichostatin A (TSA) (Pandey et al., 2008; Pascual
et al., 2012; Sakharkar et al., 2012; You et al., 2014). Utilizing
inhibitors more selective for specific HDACs (Bradner et al.,
2010) to modify histone deacetylation during EtOH withdrawal
will also help identify these mechanisms.
We identified a significant and transient induction in histone
acetylation in NAc and PFC following CIE. Notably, the CIE
paradigm escalates EtOH drinking in mice 72 h after EtOH
exposure (Becker and Lopez, 2004; Lopez and Becker, 2005;
Griffin et al., 2009) and is associated with persistent changes in
glutamate signaling in NAc (Griffin et al., 2014). Based on this
we predicted EtOH-induced histone modifications would remain
altered at this time point. A previous study also reported that 9
days of EtOH vapor resulted in increased acetylation of histone
subunits H3 and H4 in the VTA that persisted for 3 days after
EtOH exposure (Shibasaki et al., 2011). However, our results
indicate that global increases in histone acetylation induced by
high BEC’s quickly diminish during withdrawal in NAc and PFC.
Transient induction of histone acetylation in these structures
may be associated with reinforcement of EtOH consumption.
Notably, treatment with TSA, which globally increases histone
acetylation, leads to escalation of EtOH drinking in mice
(Wolstenholme et al., 2011). Induction of histone modifications
during but not immediately after EtOH exposure also fits with
studies of post-mortem tissue from human alcoholics, which
identify only modest changes in gene expression and epigenetic
modifications in the brain associated with chronic EtOH use
(Zhou et al., 2011; Ponomarev et al., 2012). Along these lines,
it is likely that changes in histone acetylation persist at specific
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FIGURE 4 | Chronic intermittent EtOH alters expression of select
chromatin modifying enzymes in NAc but not PFC. Gene
expression of a diverse set of chromatin modifying enzyme expression
was assessed using RT-qPCR. (A) There was no significant effect of
EtOH on expression of enzymes in the mPFC. (B) There was a
significant effect of chronic EtOH exposure on gene expression
(p < 0.05) and post-hoc analysis revealed significantly increased
expression of Kat5 and Tet1 as well as a trend for increased
expression of Kat2b. **p < 0.01, *p < 0.05, #p = 0.08, n = 4–5/group,
data presented as mean ± SEM.
gene promoters and mediate effects on gene expression without
widespread epigenetic dysregulation. Additional studies of gene
expression or ChIP-seq following prolonged withdrawal from
EtOH would reveal these effects.
We also identified chromatin modifying enzymes that may
mediate induction of histone acetylation in NAc. Increased
expression of the histone acetyltransferases (HAT) Kat2b (Pcaf)
and Kat5 (Tip60) correlates with induction of histone acetylation
in NAc following CIE. Kat2bwas also found to be up-regulated in
CCx during an acute EtOH exposure (Finegersh and Homanics,
2014), suggesting it is induced in multiple regions following
EtOH exposure. We identified an increase in Tet1, which
is a dioxygenase involved in active DNA demethylation in
the brain (Guo et al., 2011) and suggests CIE contributes
to active DNA demethylation in NAc. Notably, 3 weeks of
a liquid diet containing 5% EtOH was shown to decrease
global DNA methylation in brain tissue (Fowler et al., 2012).
Studying the effect of CIE on DNA methylation may reveal
a similar effect. We did not identify differential expression of
these chromatin modifying enzymes in PFC, which parallels
the less significant effect of EtOH on histone acetylation in
this region. Still, a previous study reported significantly more
differentially expressed genes in PFC compared to NAc following
CIE (Melendez et al., 2012), suggesting EtOH-induced induction
of chromatin modifying enzymes is important in PFC. Studying
expression of additional chromatin modifying enzymes may
identify those important for EtOH-induced epigenetic regulation
in PFC.
We identified a significant effect of CIE on H3K18ac but
not H3K27me3, H3S10pK14ac, H3K9ac, or H3K14ac in CCx,
indicating only a modest effect of EtOH on these histone
modifications in this brain region. Notably, H3K18ac is found
almost exclusively at the transcriptional start site of actively
transcribed genes (Wang et al., 2008), so that an increase in this
histone modification following chronic EtOH may be associated
with globally increased gene expression in CCx. Additionally,
lack of a significant effect on other histone modifications in
TABLE 4 | Summary of Bonferroni post-hoc tests for Experiment 2.
Treatment H3K9ac H3K14ac H3K18ac H3S10 H3K27me3
phK14ac
WILD TYPE
Acute EtOH 0.99 0.99 0.99 0.99 0.99
Chronic EtOH 0.99 0.99 0.02 0.99 0.99
9 h withdrawal 0.99 0.99 0.99 0.99 0.99
α1 SHLA
Acute EtOH 0.99 0.54 0.99 0.52 0.06
Chronic EtOH 0.99 0.65 0.61 0.99 0.86
9 h withdrawal 0.99 0.61 0.72 0.28 0.99
CCx is consistent with our previous study showing acute EtOH
exposure did not alter global levels of H3K27me3, H3K9ac,
or H3K14ac in CCx but did significantly increase levels of
H3K9ac and H3K14ac in the hippocampus (Finegersh and
Homanics, 2014). Lack of an effect of EtOH on histone
modifications in the CCx in this study may also be due to
the use of pyrazole in Experiment 2. Pyrazole inhibits alcohol
dehydrogenases and reduces acetaldehyde production. One study
found that acetalydehyde potentiated histone phosphorylation in
hepatocytes at a faster rate than EtOH alone (Lee and Shukla,
2007), so it is possible acetaldehyde plays a similar role in the
brain. Despite the potential effects of pyrazole, our findings
suggest that while EtOH induces differential gene expression in
CCx (Devaud et al., 1995; Pignataro et al., 2007; Finegersh and
Homanics, 2014), this structure likely has greater heterogeneity
of epigenetic mechanisms and may be more challenging to study
compared to smaller regions like the hippocampus, NAc, or PFC.
Subegion-specific differences in expression of neurotransmitter
receptors within CCx also supports this point (Jin et al., 2014).
Still, given the potential of drugs that target chromatin modifying
enzymes for treatment of AUD (Brady et al., 2002; Salloum et al.,
2005), investigating epigenetic mechanisms of EtOH in a large
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FIGURE 5 | Altered histone modifications in CCx of α1SHLA mice
following EtOH exposure. Levels of histone modifications in CCx were
measured using dot blot and revealed (A) a significant effect for genotype
(p < 0.01) for H3K27me3 and trend for decreased levels in α1 SHLA mice
compared to WT mice following acute EtOH, (B) a trend for an effect of
genotype on levels of H3S10pK14ac (p = 0.09), (C) no effect on levels of
H3K9ac, (D) an effect of genotype on levels of H3K14ac (p < 0.05), and (E)
an effect of both genotype (p < 0.05) and EtOH exposure (p < 0.05) on levels
of H3K18ac and a significant increase in H3K18ac following CIE in WT mice.
*p < 0.05, #p = 0.07, n = 6/group, data presented as mean ± SEM.
and diverse structure like CCx will improve understanding of
global epigenetic effects of EtOH and drugs used to modulate
EtOH consumption.
Our comparison of α1SHLA and WT mice across multiple
EtOH exposures revealed an effect of genotype on levels of
H3K27me3, H3K14ac, and H3K18ac as well as a trend for
an effect on H3S10pK14ac. Since there were no significant
differences in levels of histone modifications between WT and
α1SHLA room air controls, this finding suggests EtOH exposure
leads to global, subtle changes in histone modifications in CCx of
this strain. This finding is consistent with minimal differences in
basal activity and altered response to EtOH reported in this strain
(Borghese et al., 2006; Werner et al., 2006). It is also supported
by altered expression of several GABAA receptor subunits in this
strain (Borghese et al., 2006; Harris et al., 2011). Administering
HDAC inhibitors or other chromatin modifying enzymes during
EtOH exposure would reveal whether epigenetic mechanisms
mediate altered sensitivity to EtOH in this strain.
While our study examined the effects of EtOH on six
unique histone modifications, over 100 have been identified
with most having an unclear function (Tan et al., 2011). Based
on the results of this study, histone acetylation during CIE
and deacetylation during early withdrawal appear to be key
epigenetic mechanisms of EtOH action in the NAc, PFC, and
CCx. This finding parallels similar roles of EtOH-induced
histone acetylation and withdrawal-induced deacetylation in
the amygdala (Pandey et al., 2008; Sakharkar et al., 2012;
Moonat et al., 2013). However, the role of EtOH on other
histone modifications, including repressive marks like H3K27
and H3K9 methylation is not clear. These repressive histone
modifications play a role in silencing retrotransposable and
repetitive elements in the genome (Wang et al., 2008), which were
recently discovered to be upregulated in post-mortem tissue of
human alcoholics (Ponomarev et al., 2012). Therefore, studying
histone methylation and other modifications will be critical for
identify how EtOH alters chromatin to bring about changes in
expression.
In conclusion, we show that histone modifications induced
by EtOH are sensitive to changes in genotype, brain region
studied, and timing of exposure. These results have significant
implications for designing studies of epigenetic mechanisms of
EtOH and improve understanding of how EtOH regulates gene
expression.
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